January 29, 2018 / 10:14 AM / 7 months ago

BRIEF-Novo Nordisk Says Does Not Intend To Make A Revised Proposal For Ablynx

Jan 29 (Reuters) - NOVO NORDISK A/S:

* NOVO NORDISK SAYS DOES NOT INTEND TO MAKE A REVISED PROPOSAL FOR ABLYNX

* NOVO NORDISK SAYS LOOKS FORWARD TO CONTINUE ITS PRODUCTIVE RESEARCH COLLABORATION WITH ABLYNX

* FRENCH DRUGMAKER SANOFI SAID ON MONDAY IT HAS AGREED TO BUY THE BELGIAN BIOTECH COMPANY FOR 3.9 BILLION EUROS ($4.8 BILLION) FURTHER COMPANY COVERAGE: (Reporting by Stine Jacobsen)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below